![Role of immune cells in pancreatic cancer from bench to clinical application: An updated review. - Abstract - Europe PMC Role of immune cells in pancreatic cancer from bench to clinical application: An updated review. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5266022/bin/medi-95-e5541-g003.jpg)
Role of immune cells in pancreatic cancer from bench to clinical application: An updated review. - Abstract - Europe PMC
![Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-020-1147-9/MediaObjects/12935_2020_1147_Fig2_HTML.png)
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text
![Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment | Journal of Experimental & Clinical Cancer Research | Full Text Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-019-1153-8/MediaObjects/13046_2019_1153_Fig1_HTML.png)
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment | Journal of Experimental & Clinical Cancer Research | Full Text
![Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial - The Lancet Oncology Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1c36596b-4bc2-4c6a-8c3b-3cd0827a1948/gr1_lrg.gif)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial - The Lancet Oncology
![Frontiers | Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies | Immunology Frontiers | Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies | Immunology](https://www.frontiersin.org/files/Articles/642316/fimmu-12-642316-HTML/image_m/fimmu-12-642316-g001.jpg)
Frontiers | Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies | Immunology
![Cumulative numbers of cancer vaccine clinical trials for each cancer... | Download Scientific Diagram Cumulative numbers of cancer vaccine clinical trials for each cancer... | Download Scientific Diagram](https://www.researchgate.net/profile/Maria-Tornesello/publication/269281293/figure/fig1/AS:670488313491468@1536868279683/Cumulative-numbers-of-cancer-vaccine-clinical-trials-for-each-cancer-and-each-vaccination_Q640.jpg)
Cumulative numbers of cancer vaccine clinical trials for each cancer... | Download Scientific Diagram
![Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-020-1147-9/MediaObjects/12935_2020_1147_Fig1_HTML.png)
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text
![Preliminary Results Of A Phase Ib Clinical Trial Of A Neoantigen Dna Vaccine For Pancreatic Cancer - HPB Preliminary Results Of A Phase Ib Clinical Trial Of A Neoantigen Dna Vaccine For Pancreatic Cancer - HPB](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/30a83091-b73a-4ab2-94cc-67f601be8c4a/fx1.jpg)
Preliminary Results Of A Phase Ib Clinical Trial Of A Neoantigen Dna Vaccine For Pancreatic Cancer - HPB
![A sampling of current clinical trials involving pancreatic cancer and... | Download Scientific Diagram A sampling of current clinical trials involving pancreatic cancer and... | Download Scientific Diagram](https://www.researchgate.net/publication/346999181/figure/tbl3/AS:986656823848966@1612248726672/A-sampling-of-current-clinical-trials-involving-pancreatic-cancer-and-oncolytic-viruses.png)
A sampling of current clinical trials involving pancreatic cancer and... | Download Scientific Diagram
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? | Oncotarget
![Immunotherapy in pancreatic cancer treatment: a new frontier - Komal Thind, Leslie J. Padrnos, Ramesh K. Ramanathan, Mitesh J. Borad, 2017 Immunotherapy in pancreatic cancer treatment: a new frontier - Komal Thind, Leslie J. Padrnos, Ramesh K. Ramanathan, Mitesh J. Borad, 2017](https://journals.sagepub.com/na101/home/literatum/publisher/sage/journals/content/taga/2017/taga_10_1/1756283x16667909/20170113/images/large/10.1177_1756283x16667909-table9.jpeg)